Reckitt Benckiser Group (LON:RB – Get Rating) has been given a GBX 7,200 ($89.94) target price by analysts at Deutsche Bank Rese… in a research note issued to investors on Monday, Borsen Zeitung reports.
RB has been the subject of several other research reports. The Goldman Sachs Group set a GBX 6,300 ($78.70) price objective on shares of Reckitt Benckiser Group in a research report on Wednesday, April 27th. Berenberg Bank set a GBX 7,700 ($96.19) price objective on shares of Reckitt Benckiser Group in a research report on Tuesday, May 3rd. Jefferies Financial Group set a GBX 5,000 ($62.46) price objective on shares of Reckitt Benckiser Group in a research report on Friday, April 29th. Sanford C. Bernstein set a GBX 5,300 ($66.21) price objective on shares of Reckitt Benckiser Group in a research report on Friday, April 29th. Finally, Credit Suisse Group set a GBX 7,700 ($96.19) target price on shares of Reckitt Benckiser Group in a report on Wednesday, March 30th. Three investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of GBX 7,127.27 ($89.04).
Reckitt Benckiser Group has a 12 month low of GBX 5,782 ($72.23) and a 12 month high of GBX 8,020 ($100.19). The company has a quick ratio of 0.53, a current ratio of 0.77 and a debt-to-equity ratio of 116.01. The stock has a market cap of £48.36 billion and a P/E ratio of 40.79.
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
- Time to Buy These 3 Oversold Mid-Caps
- Johnson Outdoors Falls On Bleak Outlook
- Institutional Support For Tyson Foods Is Growing
- HCA Healthcare Stock is Ready to Climb Higher
- Littelfuse Stock is Hitting on All Cylinders
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.